All members have the option of attending our various HTC-centric events which include:
Date: Wednesday, February 19, 2025
Time: 1:00pm – 2:00pm ET
TITLE:
ROCTAVIAN: Improving Patient Outcomes – Latest Data & Support Initiatives
OBJECTIVE:
Join us for a webinar on ROCTAVIAN (valoctocogene roxaparvovec), the groundbreaking gene therapy for severe hemophilia A. This webinar will delve into the latest clinical data updates, showcasing the long-term efficacy and safety of ROCTAVIAN. We’ll also hear a firsthand experience from one of the patients who has received ROCTAVIAN, offering valuable insights into the real-world impact of this therapy. Finally, we will explore the comprehensive support programs available to patients, ensuring access to information, resources, and assistance throughout the treatment journey.
INTENDED AUDIENCE:
Providers, HTC staff, business administrators and decision makers
SPEAKERS:
